[go: up one dir, main page]

IS6442A - Kalsíum díkarboxýlat eterar, aðferðir til að búa þá til, og meðhöndlun á æðasjúkdómum og sykursýki með þeim - Google Patents

Kalsíum díkarboxýlat eterar, aðferðir til að búa þá til, og meðhöndlun á æðasjúkdómum og sykursýki með þeim

Info

Publication number
IS6442A
IS6442A IS6442A IS6442A IS6442A IS 6442 A IS6442 A IS 6442A IS 6442 A IS6442 A IS 6442A IS 6442 A IS6442 A IS 6442A IS 6442 A IS6442 A IS 6442A
Authority
IS
Iceland
Prior art keywords
vasculitis
diabetes
treatment
making
methods
Prior art date
Application number
IS6442A
Other languages
English (en)
Inventor
Yoshihisa Ando Howard
Eugene Butler Donald
Jay Dozeman Gary
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of IS6442A publication Critical patent/IS6442A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IS6442A 2000-01-25 2002-06-25 Kalsíum díkarboxýlat eterar, aðferðir til að búa þá til, og meðhöndlun á æðasjúkdómum og sykursýki með þeim IS6442A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25
PCT/IB2001/000026 WO2001055078A1 (en) 2000-01-25 2001-01-11 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith

Publications (1)

Publication Number Publication Date
IS6442A true IS6442A (is) 2002-06-25

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6442A IS6442A (is) 2000-01-25 2002-06-25 Kalsíum díkarboxýlat eterar, aðferðir til að búa þá til, og meðhöndlun á æðasjúkdómum og sykursýki með þeim

Country Status (39)

Country Link
EP (1) EP1259474B1 (is)
JP (1) JP4750995B2 (is)
KR (1) KR20020073182A (is)
CN (1) CN1395555A (is)
AP (1) AP2002002587A0 (is)
AR (1) AR029436A1 (is)
AT (1) ATE431326T1 (is)
AU (1) AU2214001A (is)
BG (1) BG106851A (is)
BR (1) BR0107763A (is)
CA (1) CA2397960C (is)
CO (1) CO5261537A1 (is)
CZ (1) CZ20022474A3 (is)
DE (1) DE60138686D1 (is)
DK (1) DK1259474T3 (is)
DZ (1) DZ3239A1 (is)
EA (1) EA004862B1 (is)
EE (1) EE200200404A (is)
ES (1) ES2324281T3 (is)
GE (1) GEP20053428B (is)
GT (1) GT200100015A (is)
HN (1) HN2001000011A (is)
HU (1) HUP0204422A3 (is)
IL (1) IL150541A0 (is)
IS (1) IS6442A (is)
MA (1) MA26867A1 (is)
MX (1) MXPA02007223A (is)
NO (1) NO20023526L (is)
NZ (1) NZ519550A (is)
OA (1) OA12166A (is)
PA (1) PA8510601A1 (is)
PE (1) PE20011064A1 (is)
PL (1) PL357076A1 (is)
SK (1) SK10622002A3 (is)
SV (1) SV2002000290A (is)
TN (1) TNSN01013A1 (is)
UY (1) UY26550A1 (is)
WO (1) WO2001055078A1 (is)
ZA (1) ZA200205880B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1045691T1 (en) * 1997-12-12 2005-04-30 Warner-Lambert Company Llc Statin-carboxyalkylether combinations
EP1539127A1 (en) * 2002-08-22 2005-06-15 Warner-Lambert Company Llc Method of treating osteoarthritis
JPWO2006115130A1 (ja) * 2005-04-19 2008-12-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビス[(2s)−3−[3−[(2s)−3−(4−クロロ−2−シアノフェノキシ)−2−フルオロプロポキシ]フェニル]−2−イソプロポキシプロピオン酸]カルシウム及びその中間体
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
MX372682B (es) * 2014-11-14 2020-06-18 Gemphire Therapeutics Inc Procesos e intermediarios para preparar dialcano eteres terminados con acido a, ?-dicarboxilico.
IL269884B2 (en) 2017-04-18 2023-09-01 Gemphire Therapeutics Inc Gamkaban its accepted pharmaceutical salts, their compositions and methods of their use
KR20210093900A (ko) * 2018-10-18 2021-07-28 젬파이어 세러퓨틱스 인코포레이티드 젬카빈, 이의 약학적으로 허용가능한 염, 이의 조성물 및 이의 사용 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
EA004862B1 (ru) 2004-08-26
EP1259474B1 (en) 2009-05-13
PA8510601A1 (es) 2002-08-26
AU2214001A (en) 2001-08-07
WO2001055078A1 (en) 2001-08-02
BG106851A (en) 2003-01-31
PE20011064A1 (es) 2001-10-22
ATE431326T1 (de) 2009-05-15
CA2397960A1 (en) 2001-08-02
DE60138686D1 (de) 2009-06-25
PL357076A1 (en) 2004-07-12
CO5261537A1 (es) 2003-03-31
MA26867A1 (fr) 2004-12-20
OA12166A (en) 2003-11-07
ZA200205880B (en) 2003-07-23
TNSN01013A1 (fr) 2005-11-10
NO20023526L (no) 2002-08-27
HUP0204422A3 (en) 2003-08-28
EE200200404A (et) 2003-10-15
UY26550A1 (es) 2001-08-27
NO20023526D0 (no) 2002-07-24
CN1395555A (zh) 2003-02-05
IL150541A0 (en) 2003-02-12
SV2002000290A (es) 2002-07-16
AP2002002587A0 (en) 2002-09-30
CA2397960C (en) 2008-09-09
JP4750995B2 (ja) 2011-08-17
AR029436A1 (es) 2003-06-25
HN2001000011A (es) 2001-06-13
MXPA02007223A (es) 2002-11-29
EA200200641A1 (ru) 2002-12-26
GEP20053428B (en) 2005-01-25
JP2003520835A (ja) 2003-07-08
GT200100015A (es) 2001-10-19
DK1259474T3 (da) 2009-07-20
DZ3239A1 (fr) 2001-08-02
BR0107763A (pt) 2002-11-12
ES2324281T3 (es) 2009-08-04
NZ519550A (en) 2003-11-28
HUP0204422A2 (en) 2003-05-28
KR20020073182A (ko) 2002-09-19
CZ20022474A3 (cs) 2003-06-18
EP1259474A1 (en) 2002-11-27
SK10622002A3 (sk) 2003-07-01

Similar Documents

Publication Publication Date Title
DK1534313T3 (da) Oftalmologiske irrigationsopløsninger og fremgangsmåde
NO20031776L (no) Null-boringskomplettering og produksjonssystem
NO20021426L (no) Kalsium/kalsium-magnesiumberiket vann, juice, drikkevarer og andre flytende matvarer
DK1206495T3 (da) Kimære polypeptider, fremgangsmåde til frembringelse og anvendelser deraf
DK1276551T3 (da) Kompositmembran og fremgangsmåde til fremstilling af samme
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK1370128T3 (da) Kombineret ballepresse og ballevikler
NO20031775D0 (no) Oppblåsbar pakning og fremgangsmåte
DK1641822T3 (da) Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
DE60308567D1 (de) Dekodierungsgerät, Kodierungsgerät, Dekodierungsverfahren und Kodierungsverfahren
DK1347859T3 (da) Materiale til sammenföjning og produktion fremstillet dermed
EP1248403A4 (en) DECODER AND DECODING METHOD
NO20044662L (no) Forbindelser, blandinger og fremgangsmater
IS2733B (is) Afleiður af díoxan-2-alkýlkarbamötum, framleiðsluaðferð þeirra, milliefni notuð við framleiðsluna, og notkun þeirra í meðferð.
DK1322597T3 (da) Fremgangsmåde og intermediære
EP1503370A4 (en) Coding method, coding device, decoding method and decoding device
IS6033A (is) Tálmar við amínótransferasa, sem háðir eru amínósýru með greinóttum keðjum, og notkun þeirra til meðhöndlunar á sjónusjúkdómum af völdum sykursýki
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
NO20033123L (no) Terapeutisk hinne dannende sammensetning og behandlingsplan derav
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
NO20026128D0 (no) Gelformet drivstoff, fremgangsmåte for dets fremstilling og dets anvendelse
IS6442A (is) Kalsíum díkarboxýlat eterar, aðferðir til að búa þá til, og meðhöndlun á æðasjúkdómum og sykursýki með þeim
IS7815A (is) 3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
NO20042692L (no) Sementakselerator og fremgangsmate
DK1578738T3 (da) Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf